News and Announcements
OncoSil Medical Investor Presentation March 2016
- Published March 24, 2016 12:05PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd March 2016, ASX Announcement
OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to release its latest Investor Presentation, delivered at Bell Potter Securities Limited’s Emerging Leaders Day in Sydney.
The Presentation provides an overview and update on the Company’s activities and operations.
OncoSil Medical is focused on regulatory approval and commercialisation of its OncoSil™ brachytherapy technology. It aims to position OncoSil™ as an innovative, new medical radiation treatment for pancreatic cancer and other solid tumours – which have major unmet medical needs.
To view the Presentation please click on the button below.